Fundraising Fox

VBI Vaccines Inc/BC

Cambridge, US · British Columbia, Canada corporation · 1 known investors

Find your way into VBI Vaccines Inc/BC

193 people in our graph share verified history with the VBI Vaccines Inc/BC team — schools, employers, funds. One of them is your warm intro.

Erin Mooreunlockedknows Jeff Baxter · together at GlaxoSmithKline (overlapped)
×4knows the team · via GlaxoSmithKline
×4knows the team · via CIMA
knows the team · via VBI Vaccines
×2knows the team · via University of West London
Biotech

Founders & leadership

DA
DAVID ANDERSONCHIEF SCIENTIFIC OFFICER
JM
JAMES MARTINCHIEF FINANCIAL OFFICER
CL
CURT LOCKSHINCHIEF TECHNOLOGY OFFICER
JBJEFF BAXTER
JEFF BAXTERinCHIEF EXECUTIVE OFFICER AND PRESIDENTJeff Baxter is CEO and President of VBI Vaccines Inc, a vaccine development company. He previously served as managing partner at The Column Group venture capital firm and spent 19 years in pharmaceutical roles at GlaxoSmithKline, including SVP of R&D Finance and Operations, along with earlier positions at Unilever; he holds an FCMA credential from the Chartered Institute of Management Accountants.
DC
Dorothy ChinExecutive
RT
Ron TremblayExecutive
VC
Vic ChevillonExecutive
AC
Annie ChanExecutive

Board

AL
ADAM LOGALBoard director
SR
STEVEN RUBINBoard director
SG
STEVEN GILLISBoard director
SC
SAM CHAWLABoard director

Investors · 1

ClarusreportedCambridge

Reported raises · per SEC filings

Form D private placements

$41.4M disclosed across 6 of 7 rounds · 2014–2022

▶Undisclosed amountofferedSep 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Damian BragaDirector
  • Joanne CordeiroDirector
  • Blaine McKeeDirector
  • Christopher McNultyExecutive Officer
  • Jeffrey R. BaxterExecutive Officer, Director
  • Steven GillisDirector
  • Michel De WildeDirector
First sale
Sep 2022
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedMay 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff BaxterExecutive Officer, Director
  • David E. AndersonExecutive Officer
  • Damian BragaDirector
  • Joanne CordeiroDirector
  • Blaine McKeeDirector
  • Steve GillisDirector
  • Avi MazaltovExecutive Officer
  • Nell BeattieExecutive Officer
  • Christopher McNultyExecutive Officer, Director
  • Francisco Diaz-MitomaExecutive Officer
  • Michel De WildeDirector
Offering amount
$4.7M
Amount sold
$4.7M
First sale
May 2020
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMay 2020 · 61 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Avi MazaltovExecutive Officer
  • Jeff BaxterExecutive Officer, Director
  • Steve GillisDirector
  • Michel De WildeDirector
  • Damian BragaDirector
  • Francisco Diaz-MitomaExecutive Officer
  • David E. AndersonExecutive Officer
  • Blaine McKeeDirector
  • Joanne CordeiroDirector
  • Nell BeattieExecutive Officer
  • Christopher McNultyExecutive Officer, Director
Offering amount
$1.1M
Amount sold
$1.1M
First sale
Apr 2020
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedDec 2018 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nell BeattieExecutive Officer
  • Michel De WildeDirector
  • Steve GillisDirector
  • Tomer KarivDirector
  • Christopher McNultyExecutive Officer
  • Jeff BaxterExecutive Officer, Director
  • Avi MazaltovExecutive Officer
  • Francisco Diaz-MitomaExecutive Officer
  • Scott RequadtDirector
  • David E. AndersonExecutive Officer
  • Athena KartsaklisExecutive Officer
Offering amount
$7M
Amount sold
$7M
First sale
Dec 2018
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.6MraisedDec 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • SCOTT REQUADTDirector
  • MICHEL DE WILDEDirector
  • JEFF BAXTERExecutive Officer, Director
  • SAM CHAWLADirector
  • EGIDIO NASCIMENTOExecutive Officer
  • STEVEN GILLISDirector
  • CURT LOCKSHINExecutive Officer
  • STEVEN RUBINDirector
  • ADAM LOGALDirector
Offering amount
$10.6M
Amount sold
$10.6M
First sale
Dec 2016
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.6MraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHEL DE WILDEDirector
  • DAVID ANDERSONExecutive Officer
  • ADAM LOGALDirector
  • JAMES MARTINExecutive Officer
  • STEVEN RUBINDirector
  • STEVEN GILLISDirector
  • SAM CHAWLADirector
  • CURT LOCKSHINExecutive Officer
  • SCOTT REQUADTDirector
  • JEFF BAXTERExecutive Officer, Director
Offering amount
$13.6M
Amount sold
$13.6M
First sale
Jun 2016
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedNov 2014 · 11 investors · Other
Rule 506(c)
Officers, directors & promoters on the filing
  • Gary RobertsonDirector
  • Carlos H. Fernandez-MazziDirector
  • William C. GlasierDirector
  • Dorothy ChinExecutive Officer
  • Ron TremblayExecutive Officer, Director
  • Ron BarbaroDirector
  • Vic ChevillonExecutive Officer, Director
  • Annie ChanExecutive Officer
  • Robert RobertsDirector
Offering amount
$4.4M
Amount sold
$4.4M
First sale
Oct 2014
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded VBI Vaccines Inc/BC?
VBI Vaccines Inc/BC was founded by DAVID ANDERSON.
Who are VBI Vaccines Inc/BC's investors?
VBI Vaccines Inc/BC's investors include Clarus.
How much funding has VBI Vaccines Inc/BC raised?
VBI Vaccines Inc/BC has disclosed $41.4M raised across 6 of its 7 known rounds.
Where is VBI Vaccines Inc/BC headquartered?
VBI Vaccines Inc/BC is headquartered in Cambridge, US.